What Boston Scientific Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 6 | 10 |
| Sells | 0 | 8 |
| Total trades | 12 | 132 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 296,888 | 1,203,234 |
| Disposed | 567 | 1,038,898 |
| Net activity | +296,321 | +164,336 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| O'Connor Padraig Andrew | EVP, Global Operations | Sep 02 | Withheld — tax / exercise cost · F | −567 | $48.37 | −$27.4K | 7,892 |
| O'Connor Padraig Andrew | EVP, Global Operations | Sep 02 | Exercise / conversion · M | +1,171 | — | — | 8,459 |
| Morano Susan E | Director | Aug 25 | Open-market buy · P | +2,040 | $49.22 | +$100K | 13,784 |
| Woodworth Emily | SVP, Global Controller and CAO | Aug 11 | Discretionary Transaction · I | +2,930 | $51.19 | +$150K | 2,930 |
| Monson Jonathan | EVP and CFO | Aug 10 | Discretionary Transaction · I | +9,908 | $50.46 | +$500K | 9,908 |
| Habiger Dave | Director | Aug 05 | Open-market buy · P | +2,100 | $47.59 | +$99.9K | 17,160 |
| Habiger Dave | Director | Aug 04 | Open-market buy · P | +140 | $48.59 | +$6.8K | 15,060 |
| Mahoney Michael F | Chairman, President & CEO | Aug 03 | Discretionary Transaction · I | +22,119 | $48.43 | +$1.07M | 22,119 |
| Mahoney Michael F | Chairman, President & CEO | Aug 03 | Open-market buy · P | +186,240 | $48.33 | +$9M | 1,590,024 |
| Habiger Dave | Director | Aug 03 | Open-market buy · P | +1,042 | $48.07 | +$50.1K | 14,920 |
| Ludwig Edward J | Director | Jul 31 | Open-market buy · P | +5,000 | $45.48 | +$227K | 30,359 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Jul 31 | Discretionary Transaction · I | +64,198 | $46.73 | +$3M | 64,198 |
| Monson Jonathan | EVP and CFO | Jul 01 | Withheld — tax / exercise cost · F | −1,010 | $43.06 | −$43.5K | 39,063 |
| Monson Jonathan | EVP and CFO | Jul 01 | Exercise / conversion · M | +2,087 | — | — | 40,073 |
| Mahoney Michael F | Chairman, President & CEO | May 28 | Gift · G | −386,755 | — | — | 0 |
| Ludwig Edward J | Director | May 20 | Open-market buy · P | +3,580 | $56.68 | +$203K | 25,359 |
| Pegus Cheryl | Director | May 20 | Open-market buy · P | +1,770 | $56.49 | +$100K | 1,770 |
| Habiger Dave | Director | May 20 | Open-market buy · P | +2,250 | $55.92 | +$126K | 13,878 |
| Habiger Dave | Director | May 19 | Open-market buy · P | +2,200 | $56.95 | +$125K | 11,628 |
| Ludwig Edward J | Director | May 07 | Grant / award · A | +3,800 | — | — | 21,779 |
Loading...
